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Abstract: In the present study, selenium (Se) nanoclusters were grown through heterogeneous 
nucleation on titanium (Ti) surfaces, a common orthopedic implant material. Normal healthy 
osteoblasts (bone-forming cells) and cancerous osteoblasts (osteosarcoma) were cultured on 
the Se-doped surfaces having three different coating densities. For the first time, it is shown that 
substrates with Se nanoclusters promote normal osteoblast proliferation and inhibit cancerous 
osteoblast growth in both separate (mono-culture) and coculture experiment. This study suggests 
that Se surface nanoclusters can be properly engineered to inhibit bone cancer growth while 
 simultaneously promoting the growth of normal bone tissue.
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Introduction
It is estimated that 2,380 individuals will be diagnosed with bone and joint cancer 
and 1,470 individuals will die from primary bone and joint cancer in 2008 in the 
US.1 Primary bone cancer is rare, as usually bone cancer is a result of the spread 
of cancer from other organs (such as the lungs, breasts and prostate). A common 
technique to treat bone cancer is the surgical removal of cancerous tissue fol-
lowed by insertion of an orthopedic implant to restore patient functions. However, 
sometimes the cancerous cells are not completely removed. Therefore, it would be 
beneficial to have implants specifically designed to prevent the occurrence and reoc-
currence of bone cancer and promote healthy bone tissue growth. Unfortunately, 
current materials used as orthopedic implants (such as titanium, stainless steel, and 
ultra-high-molecular-weight polyethylene) do not possess anticancer properties 
and, thus, have no inherent mechanisms to keep cancer from reoccurring.
Recently, we have introduced a new anticancer bone implant, which combines 
the carcinostatic activity of selenium with the well known mechanical properties of 
the traditional implant material, titanium.2,3 This novel anticancer orthopedic implant 
 material was created by heterogenous nucleation of selenium nanoclusters on the 
 surface of titanium. It was shown in separate culture experiments that selenium doping 
on surfaces increased healthy osteoblast and decreased cancerous osteoblast functions.2 
The objective of the present in vitro coculture study on this novel material was to simul-
taneously: (i) promote normal bone cell functions and (ii) inhibit cancerous bone cell 
functions. As a trace element in humans and animals, Se plays important roles in many 
processes such as antioxidant defense systems, thyroid hormone metabolism and redox 
control of cell reactions.4 Selenium consumed in excess of the nutritional requirement 
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can inhibit and/or retard carcinogenesis in animals.5 High 
 levels of Se in the blood (∼154 µg/mL) have been correlated 
with reduced numbers of cancers including pancreatic, 
gastric, lung, nasopharyngeal, breast, uterine, respiratory, 
digestive, hematological and gynecological.6 Selenium has 
also been shown to inhibit the growth of many cancerous 
cell lines in vitro. For example, culture media enriched 
with Se in the form of sodium selenite, selenomethionine, 
or selenocysteine inhibited malignant mesothelioma (MM) 
cells in a dose-dependent manner via apoptosis-related 
mechanisms to SEP15 which is a gene encoding a 15-kDa 
Se-containing protein.7 However, normal mesothelial cells 
were not affected. In spite of a great number of studies on 
the effect of selenium compounds on cancer, there are very 
few experiments focusing on the effect of substrate-bound 
elemental Se nanoclusters on cancer growth. The mecha-
nisms of Se-based chemoprevention are also complex and 
incompletely understood.8
To promote normal osteoblast functions, we focused 
on introducing selenium in a manner that also produces 
a nanostructured surface,3 since numerous studies have 
shown increased osteoblast functions (including adhesion, 
 proliferation, differentiation, protein synthesis and cal-
cium-containing mineral deposition) on nanorough surfaces 
compared to microrough, nanosmooth surfaces.9–14 It was 
also shown that initial protein interactions from serum on 
nanostructured ceramics11,14 and nanophase metals10 was 
 optimal, leading to greater osteoblast functions. The increased 
osteoblast functions on nanophase compared to micron, con-
ventional ceramics was also independent of surface chemistry 
and material crystalline phase.13
Here, we demonstrate through both mono- and coculture 
experiments that Se nanoclusters heterogeneously nucleated 
on titanium orthopedic material surfaces have the potential 
to achieve the dual goals of increasing normal bone cell 
 functions and decreasing cancerous bone cell growth.
Materials and methods
Materials
Titanium (Ti) substrates (Alfa Aesar, Ward Hill, MA, USA) 
were individually degreased and sonicated in acetone and 
ethanol for 10 min. Degreased substrates were then ster-
ilized by autoclaving at 121°C for 30 min. Cleaned and 
sterilized substrates were used as a base substrate for the 
colloidal decoration with Se nanoclusters. The substrates 
were exposed to 4:1 molar mixtures of glutathione (GSH, 
reduced form; TCI America, Portland, OR, USA) and sodium 
selenite (Na
2
SeO
3
; Alfa Aesar) in the concentration ranges 
shown in Table 1.
Three different solution concentrations (Table 1) 
were used to achieve different doses denominated as low, 
medium, and high Se doses. After a gentle mixing of the 
solutions in the reaction beaker, 1M NaOH was introduced 
to bring the pH into the alkaline regime. The reaction mix-
ture was once again gently mixed and left undisturbed for 
10 min. The substrates were withdrawn from the beaker 
and rinsed in deionized water. The uncoated and coated 
substrates were exposed to ultraviolet (UV) light for 
24 hours on each side to sterilize them before use in cell 
experiments.
Surface characterization
Surfaces of the uncoated and Se-coated Ti substrates were 
visualized using a scanning electron microscope (SEM; LEO 
1530VP FE-4800) with an accelerating voltage from 3 kV to 
10 kV. To test the strength of Se nanocluster attachment, the 
coated substrates were subjected to sonication for 10 min at 
90 W (ultrasonic cleaner 75D, VWR).
Surface hydrophilicity/hydrophobicity was also deter-
mined in this study by measuring the contact angle of water 
on the substrates of interest using a contact angle analyzer 
(EasyDrop; Krüss, Hamburg, Germany). For that, 2 µL water 
drops were dispensed using appropriate software (Drop Shape 
Table 1 Reagent volumes used in the colloidal synthesis of Se nanoclusters in the presence of Ti2
Reagent Preparation method
*[Se] = 0.42 mM [Se] = 0.84 mM [Se] = 1.68 mM
“Low Dose” “Medium Dose” “High Dose”
Deionized water 14.5 ml 14 ml 13 ml
100 mM glutathione (GSH) 0.25 ml 0.5 ml 1 ml
25 mM Na2SeO3 0.25 ml 0.5 ml 1 ml
Final volume 15 ml 15 ml 15 ml
Notes: *[Se] = Final concentration of Se in the colloidal synthesis solution.
Abbreviations: Se, selenium; Ti, titanium.
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Analysis; Krüss) and contact angles were measured every 
second and averaged within the first 15 seconds of dispensing. 
Surface energies of the uncoated Ti and nanoselenium-coated 
Ti were determined from the measured contact angles using 
appropriate software (Drop Shape Analysis).
Cell assays
Separate cell culture assays
To investigate the density of normal healthy noncancerous 
osteoblasts and cancerous osteoblasts on the uncoated 
and Se-coated Ti substrates, either primary human cal-
varial osteoblasts (bone-forming cells; ScienCell Research 
 Laboratories, Carlsbad, CA, USA) in appropriate osteoblast 
cell culture medium (ObM; ScienCell Research Laborato-
ries) or mouse osteosarcoma osteoblasts (ATCC, population 
numbers 14–17) in Dulbecco’s modified Eagle medium 
(DMEM) supplemented with 10% fetal bovine serum 
(FBS; Hyclone, South Logan, UT, USA) and 1% penicillin/
streptomycin (P/S; Hyclone) were seeded at a density of 
3500 cells/cm2 and placed in an incubator under standard 
cell culture conditions (37°C, 5% CO
2
, 95% humidified air) 
for three days. After the desired time period, cells were 
fixed using formaldehyde 4% (Sigma Aldrich, St. Louis, 
MO, USA), stained with 4′,6-diamidino-2-phenylindole 
(DAPI, ATCC), and counted under fluorescence micros-
copy (Zeiss Axiovert 200M Light Microscope; Carl Zeiss, 
Thornwood, NY, USA) in five random fields (averaged for 
each substrate).
Coculture assays
To investigate the density of both normal and cancerous 
osteoblasts when cocultured, normal osteoblasts and 
 cancerous osteoblasts (described above) were pre-stained 
with the fluorescent dyes Vybrant DiO and Vybrant DiD 
(Molecular Probes, Eugene, OR, USA), respectively, and 
then seeded simultaneously in a media consisting of 50% 
DMEM and 50% ObM (as described above) at a density of 
750 cells/cm2 (for each cell type) on either uncoated Ti or Ti 
coated with the high dose of Se in an incubator under standard 
cell culture conditions. Media was exchanged and cells were 
observed under fluorescence microscopy at 4, 17, 24, 40, 
53, and 65 hours. Cells were counted under fluorescence 
microscopy in five random fields and were averaged for 
each substrate.
Statistical analysis
Experiments were conducted in triplicate and repeated three 
times. Data were collected and significant differences were 
assessed with the probability associated with one-tailed 
Student’s t-tests.
Results
Surface characterization
SEM images of the uncoated and Se-coated material sur-
faces demonstrated the presence of Se nanoclusters and 
an apparent cluster surface density that increased from 
the low-dose to the medium-dose and high-dose Se cases 
(Figure 1). The Se nanoclusters were approximately 80 nm 
in diameter. These Ti substrates will be referred to as uTi, 
Low-nSe-Ti, Medium-nSe-Ti and High-nSe-Ti for uncoated 
Ti, and low, medium, and high Se dose-coated Ti substrates, 
respectively.
The Se morphology on the substrates appeared to be 
identical by SEM before and after sonication as well as after 
UV treatment for 24 hours (data not shown).
Uncoated Ti substrates were hydrophilic with an average 
water contact angle of approximately 55°. Importantly, 
 coating Ti with selenium nanoclusters made the Ti surfaces 
more hydrophobic (Figure 2).
Cell experiments
Separate cell culture assays
After three days of culture, normal healthy osteoblast 
 densities significantly increased on High-nSe-Ti compared 
to uTi and Low-nSe-Ti (Figures 3 and 4).
In contrast, for cancerous osteoblasts, after three days, cell 
densities were significantly higher on uTi and Low-nSe-Ti 
than on High-nSe-Ti (Figures 5 and 6). Specifically, cancerous 
osteoblast densities on Medium-nSe-Ti and High-nSe-Ti were 
significantly lower than on Low-nSe-Ti. Cancerous osteoblast 
A B
DC
Figure 1 Representative SEM images of uncoated Ti A) and Se-coated Ti with low 
B) medium C) or high D) doses of Se nanoclusters.
Note: Scale bars are 500 nm.
Abbreviations: Se, selenium; SEM, standard error of mean; Ti, titanium.
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Figure 2 Water contact angles on the uncoated and Se-coated Ti substrates. Contact angles increased on the substrates coated with selenium nanoclusters.
Notes: Data = mean ± SEM; N = 3; *P  0.05 compared to all the coated substrates. There was no significant difference among the contact angles on the coated substrates.
Abbreviations: Se, selenium; SEM, standard error of mean; Ti, titanium.
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Figure 3 Normal osteoblast densities increased on Se-coated Ti substrates after three days of culture.
Notes: Data = mean ± SEM; N = 3; *P  0.05 compared to uTi.
Abbreviations: Se, selenium; SEM, standard error of mean; Ti, titanium; uTi, uncoated Ti.
densities on High-nSe-Ti wer also significantly lower than on 
Medium-nSe-Ti (Figures 5 and 6).
Coculture assays
Coculture experiments were conducted only for two 
types of substrates, uTi (control) and High-nSe-Ti (which 
is the Se-coated substrate that had the highest normal 
healthy osteoblast density and the lowest cancerous 
osteoblast density from individual cell experiments). On 
the uncoated Ti substrates, cancerous osteoblast densities 
increased with time while healthy osteoblast densities did 
not change significantly among the different time points 
(Figure 7).
In contrast, significantly increased normal healthy 
osteoblast densities were observed after 53 and 65 hours 
when cocultured on High-nSe-Ti substrates suggesting a 
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Figure 4 Fluorescence microscopy images of normal healthy osteoblasts stained with 
DAPI after three days of culture on uTi A) Low-nSe-Ti B) Medium-nSe-Ti C) and 
High-nSe-Ti D) Scale bars are 100 µm.
Abbreviations: DAPI, ; Se, selenium; SEM, standard error of mean; Ti, titanium; uTi, 
uncoated Ti.
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Figure 5 Decreased cancerous osteoblast densities on the Se-coated substrates after three days of culture.
Notes: Data = mean ± SEM; N = 3; *P  0.01 compared to uTi; **P  0.01 compared to Low-nSe-Ti; ***P  0.05 compared to Medium-nSe-Ti.
Abbreviations: Se, selenium; SEM, standard error of mean; Ti, titanium.
more favorable environment for healthy than cancerous 
osteoblasts on Se-coated Ti (Figure 8). Importantly, there 
was no significant change in cancerous cell densities on 
High-nSe-Ti among the different time points of the present 
study.
Discussion
Creating nanostructured surfaces to enhance osteoblast 
 functions (including collagen, alkaline phosphatase, and 
 calcium deposition) has been reported in a number of studies. 
For example, nanostructured (formulations with grain sizes 
less than 100 nm) metals, ceramics, and polymers have been 
shown to enhance osteoblast adhesion, proliferation and 
 differentiation.9–14 In particular, Ti, Ti6Al4V, and CoCrMo 
with nanorough surfaces have been shown to enhance 
 osteoblast adhesion compared to conventional (formulations 
with grain sizes greater than 100 nm) respective metal 
 surfaces.10 For example, nanophase alumina (23 nm grain 
size) and nanophase titania (32 nm grain size) showed greater 
 osteoblast adhesion compared to conventional, microphase 
alumina (177 nm grain size) and titania (2120 nm grain 
size).14 In addition, nanotube patterns on polycarbonate 
urethane (PCU) were demonstrated to decrease macrophage 
(cells that contribute to harmful chronic inflammation) den-
sity.15 Nanostructured ZnO and TiO
2
 surfaces were shown 
to decrease the adhesion and colonization of Staphylcoccus 
epidermidis which is the leading bacteria infecting orthopedic 
implants.16
Here, we used an anticancer implant material created 
by nanorough surface features on Ti using Se which is 
a trace element naturally found in the human body that 
has been shown to prevent various types of cancer from 
occurring and/or developing.5–7,17–35 The goal of this work 
was to demonstrate the potential of Se-containing nano-
structured implant surfaces to support healthy osteoblast 
functions but inhibit cancerous osteoblast functions. To 
achieve this goal, we precipitated adherent Se nanoclusters 
by a colloidal-phase reaction on clean Ti surfaces. Various 
Se nanocluster densities were achieved by varying the Se 
concentration in the synthesis solutions. Ultrasonication 
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Figure 6 Fluorescence microscopy images of cancerous osteoblasts stained with 
DAPI after three days of culture on uTi A) Low-nSe-Ti B) Medium-nSe-Ti C) and 
High-nSe-Ti D).
Note: Scale bars are 100 µm.
Abbreviations: DAPI, ; Se, selenium; SEM, standard error of mean; Ti, titanium.
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Figure 7 Increased cancerous osteoblast density after 65 hours of coculturing cancerous and healthy osteoblasts on uncoated Ti. Healthy osteoblast densities showed no 
significant change on uncoated Ti.
Notes: Data = mean ± SEM; N = 3.
Abbreviations: Se, selenium; SEM, standard error of mean; Ti, titanium.
tests demonstrated that Se nanoclusters strongly adhered 
to the Ti surfaces.
When the Se-coated substrates were used in separate 
cell culture experiments, normal bone cell proliferation 
increased while cancerous bone cell proliferation decreased 
compared to the uncoated Ti substrates. The increased normal 
bone cell proliferation is likely attributed to the greater 
number of nanofeatures on the Ti substrates coated with Se 
 nanoclusters. This is because studies have demonstrated that 
increased implant nanoscale surface roughness led to greater 
 adsorption of proteins (such as fibronectin and vitronectin) 
which mediate osteoblast adhesion.12,13
Importantly, this study also showed that the competitive 
proliferation of cancerous bone cells was inhibited on 
Ti-coated with Se nanoclusters. In single cell culture 
 experiments, the inhibitory effect was dose-dependent; 
a higher dose of Se nanocluster coating density resulted in a 
greater inhibited cancerous bone cell proliferation.
The mechanism of Se-induced inhibited bone cell cancer 
growth is likely complex and remains to be elucidated. 
However, our previous results have indicated that soluble 
Se formulations released in cell culture media inhibited 
 cancerous osteoblast growth while it did not have any effects 
on the growth of normal healthy osteoblasts. Therefore, it is 
likely that the biologically active species decreasing cancer 
cell density is soluble Se, either selenide or selenite, gradually 
released from the biologically inert Se0 nanoclusters in the 
presence of cell culture components. Some of the differences 
in cell growth may also be related to the modest changes 
observed in surface energy and hydrophilicity upon Se 
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Figure 8 Increased healthy osteoblast density after 53 and 65 hours of coculturing cancerous and healthy osteoblasts on High-nSe-Ti. Cancerous osteoblasts did not show 
any significant difference in density on Se-coated Ti.
Notes: Data = mean ± SEM; N = 3.
Abbreviations: Se, selenium; SEM, standard error of mean; Ti, titanium.
 doping. Trends may also be related to the presently reported 
changes in hydrophobicity of the Se-coated compared to 
uncoated Ti samples. In the clinical situation where cancer 
cells are not completely removed during surgery, one will 
encounter situations where both normal healthy osteoblasts 
and cancerous osteoblasts are present at the implant site. 
Therefore, coculture experiments were conducted here in 
which both cancerous osteoblasts and normal osteoblasts 
were seeded together on either uncoated Ti or high dose Se-
coated Ti. For the first time, we report two interesting results: 
(i) on the uncoated Ti substrates, cancerous osteoblast density 
increased with time while healthy osteoblast density did not 
change significantly over the tested time period; and (ii) on 
the Se-coated Ti substrate, cancerous osteoblast density did 
not significantly change while healthy osteoblast density 
significantly increased after 53 and 65 hours.
It is intriguing that normal osteoblasts did not 
 proliferate on uTi in the presence of cancerous osteoblasts. 
Although more investigation is needed, this could be due 
to the competition for nutrients by these cells and implant 
space occupied by the cancerous cells that inhibited the 
 proliferation of normal healthy osteoblasts. Importantly, 
on the Ti coated with a high amount of Se nanoclusters, 
healthy osteoblast proliferation was enhanced after 53 and 
65 hours while the proliferation of cancerous osteoblasts 
was inhibited during these time periods. In this study, 
we used the same seeding densities for both normal and 
 cancerous osteoblasts. However, in clinical situations where 
cancerous osteoblasts are present at the implant site, as the 
result of incomplete tumor removal, most likely there will 
be more healthy osteoblasts than cancerous osteoblasts. 
Therefore, the trend demonstrated here (ie, decreased 
 cancerous osteoblast and increased normal osteoblast 
densities) may be amplified leading to a faster integration 
of the implant into healthy bone and a stronger osteoblast 
cancerous inhibitory effect.
Conclusions
This study showed that Se nanocluster coatings on Ti can 
transform a normal orthopedic material into a cancer-
inhibiting implant. The coating densities are controllable 
by varying reagent concentration in the simple fabrication 
process described here. This work showed that, in the range 
of Se doses tested, cancerous osteoblast functions were 
inhibited, while healthy osteoblast functions were promoted 
when cultured separately or together on the same substrate. 
Further in vitro and in vivo studies should be conducted 
to examine the potential of Se nanocluster coatings for 
improving orthopedic implants.
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